Volume 68, Issue 1, Pages (January 2018)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 61, Issue 1, Pages (July 2014)

Volume 63, Issue 1, Pages (July 2015)

Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response Henry Lik–Yuen Chan, Vincent.

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 46, Issue 3, Pages (March 2007)

Volume 60, Issue 2, Pages (February 2014)

Inflammasomes in liver diseases

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Volume 68, Issue 5, Pages (May 2018)

Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Huge Adrenal Hemangioma: A Rare Cause of Deceivingly High Liver Stiffness Measurement by Transient Elastography Grace Lai-Hung Wong, Raymond Kwok, Vincent.

Immigration and viral hepatitis

Marcus-Alexander Wörns, Peter Robert Galle Journal of Hepatology

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Hepatitis B and C virus-related carcinogenesis

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

Volume 44, Pages S19-S24 (January 2006)

The place of downstaging for hepatocellular carcinoma

AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.

Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B W.-K. Seto, D. K.-H. Wong,

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Volume 65, Issue 4, Pages (October 2016)

European Association for the Study of the Liver Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Correction Journal of the American College of Surgeons

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B Yasuji Arase, MD, Kenji Ikeda, MD, Fumitaka Suzuki,

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Trends in the management and burden of alcoholic liver disease

Volume 42, Issue 2, Pages (February 2005)

Why men are at higher risk for hepatocellular carcinoma?

Volume 62, Issue 3, Pages (March 2015)

Ming-Ling Chang, Yun-Fan Liaw Journal of Hepatology

Genomic risk of hepatitis C-related hepatocellular carcinoma

Autophagy in the liver Journal of Hepatology

Volume 66, Issue 2, Pages (February 2017)

EASL Clinical Practice Guidelines: Wilson’s disease

A.H. Gifford Journal of Cystic Fibrosis

Hepatitis B and C virus-related carcinogenesis

The role of quantitative hepatitis B surface antigen revisited

Development of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen Myron John Tong, Michael Ong Nguyen, Lori Terese Tong, Lawrence.

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Paul C. Adams, James C. Barton Journal of Hepatology

Volume 135, Issue 4, Pages (October 2008)

Chetana Lim, Chady Salloum, Daniel Azoulay

Immigration and viral hepatitis

Evolution of liver transplantation for hepatocellular carcinoma

Volume 64, Issue 6, Pages (June 2016)

Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma

Volume 63, Issue 1, Pages (July 2015)

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc,

Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response Henry Lik–Yuen Chan, Vincent.

Volume 62, Issue 4, Pages (April 2015)

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence Christian Toso, Gilles Mentha, Pietro.

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Genetics of hepatocellular carcinoma: The next generation

MELD: the holy grail of organ allocation?

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Volume 68, Issue 1, Pages 208-209 (January 2018) Reply to: “Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance” Terry Cheuk-Fung Yip, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Grace Lai-Hung Wong Journal of Hepatology Volume 68, Issue 1, Pages 208-209 (January 2018) DOI: 10.1016/j.jhep.2017.08.026 Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Kaplan-Meier analysis of HCC in four subgroups in patients with available FIB-4 at the time of HBsAg seroclearance. FIB-4, Fibrosis-4 score; HBsAg, hepatitis B surface antigen; HCC, hepatocellular carcinoma. Journal of Hepatology 2018 68, 208-209DOI: (10.1016/j.jhep.2017.08.026) Copyright © 2017 European Association for the Study of the Liver Terms and Conditions